(VCBeat) Apr. 14, 2021 -- Recently, yaodouwang.com, a Chinese online pharmaceutical retailer, has completed a Series C financing of hundreds of millions, led by Morgan Stanley with participation from the existing investor Nanxi Venture Capital.
The funds are earmarked for the construction of the talent team, central and front-end warehouses, improvement of the warehousing and distribution capacity of the supply chain system and the sales network of S2B2C. In addition to constantly improving the national business, yaodouwang.com is also strengthening its technical capability system and service coverage for small and medium terminals.
yaodouwang.com is a comprehensive online service platform for drug selling. It has been deeply engaged in the pharmaceutical market out of hospitals, with competitiveness in market approvals, medicine circulation, cross-border e-commerce, and bonded goods. By the "two networks, one warehouse, and one store" business model, yaodouwang.com builds an efficient online supply chain system and sales network covering the whole country. It is committed to building China's leading "medical+ drug + insurance" smart medical service and retail platform, providing more convenient and more favorable drug use and health services for the Chinese people.
After this round of financing, yaodouwang.com will continue to deepen the online distribution business, enhance the digital capabilities of its platform, empower the whole pharmaceutical industry chain with science and technology, improve its core competitive advantage in the field of Internet pharmaceutical distribution, and build a closed loop of "medical + drug + insurance" business.
About Morgan Stanley
Morgan Stanley is an American multinational investment bank and financial services company headquartered at 1585 Broadway in the Morgan Stanley Building, Midtown Manhattan, New York City. With offices in more than 42 countries and more than 60,000 employees, the firm's clients include corporations, governments, institutions, and individuals. Morgan Stanley ranked No. 67 in the 2018 Fortune 500 list of the largest United States corporations by total revenue.